1. Levine Cancer Institute/Carolinas HealthCare System, Charlotte, NC;
2. Division of Hematology-Oncology, Department of Medicine, Abramson Cancer Center and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;
3. Vejle Hospital and University of Southern Denmark, Vejle, Denmark;
4. Tom Baker Cancer Center–University of Calgary, Calgary, AB, Canada;
5. Cross Cancer Institute, Edmonton, AB, Canada;
6. Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA;
7. Department of Hematology, VU Medical Center, Amsterdam, The Netherlands;
8. Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC;
9. Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
10. Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY;
11. Janssen Research & Development, LLC, Spring House, PA;
12. Janssen Research & Development, LLC, Raritan, NJ; and
13. Karolinska Institute, Division of Hematology, Department of Medicine, Karolinska University Hospital at Huddinge, Stockholm, Sweden